In this issue:
- Glucocorticoids for CAP
- Optimal antibiotic duration for respiratory tract infections
- GP consultations for respiratory tract infections in under 5s
- Clinical spectrum and incidence of severe acute group A streptococcus
- Vaccine-preventable CAP in Germany
- COVID-19 vaccine outcomes in US veterans
- Updated evidence for COVID-19, RSV and influenza vaccines for 2025–2026
- AS01E-adjuvanted RSVPreF3 OA vaccine over three seasons
- Modified mRNA influenza vaccine
- Adjunctive corticosteroids in non-HIV severe P. jirovecii pneumonia
- Colchicine for long-COVID
- COVID-19 rehabilitation after hospitalisation
Please login below to download this issue (PDF)